Table 1.
Patients characteristics
| Number of patients | 45 | |
|---|---|---|
| Median age (range) | 68 (22–86) | |
| Gender, no. (%) | Male | 19 (42,2%) |
| Female | 26 (57,8%) | |
| Histhology, no. (%) | MZL, MALT type | 45 (100%) |
| Lesion site, no. (%) | Ocular- adnexa | 16 (35,5%) |
| Head and Neck | 12 (26,7%) | |
| Othersa | 17 (37,8%) | |
| Stage no. (%) | I | 36 (80%) |
| II | 1 (2,2%) | |
| III | 1 (2,2%) | |
| IV | 7 (15,6%) | |
| Bulkyb lesions, no. (%) | Yes | 1 (2,2%) |
| No | 44 (97,8%) | |
| Diagnostic Imaging, no. (%) | Mx | 1 (2,2%) |
| US | 8 (17,8%) | |
| CT | 39 (86,7%) | |
| MRI | 22 (48,9%) | |
| PET | 10 (22,2%) |
CT, Computed tomography; MALT, mucosa-associated lymphoid tissue; MRI, Magnetic resonance imaging; MZL, Marginal zone lymphoma; Mx, Mammography; PET, Positron emission tomography; US, Ultrasound imaging.
a
Others = breast+kidney, (1) lung, (1) thyroid, (1) liver, (1) dura mater, (1) spleen, (2) skin, (3) subcutis, (2) para-bladder, (1) para-cardiac, (1) lymph nodes (4).
b
Bulky = maximum diameter > 5 cm.